Stock RNAC CARTESIAN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Cartesian Therapeutics, Inc.

Equities

RNAC

US8162123025

Real-time Estimate Cboe BZX
Other stock markets
 12:38:34 2024-06-06 pm EDT 		5-day change 1st Jan Change
37.44 USD +2.90% Intraday chart for Cartesian Therapeutics, Inc. +20.79% +83.61%
Jun. 04 Oppenheimer Initiates Cartesian Therapeutics With Outperform Rating, $50 Price Target MT
May. 24 Mizuho Securities Starts Cartesian Therapeutics With Buy Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. RNAC Stock
  4. Revisions Cartesian Therapeutics, Inc.